XML 39 R28.htm IDEA: XBRL DOCUMENT v3.20.2
Financial Instruments and Risk Management (Tables)
9 Months Ended
Jun. 27, 2020
Fair Value Disclosures [Abstract]  
Fair value of the Partnership's derivative instruments and their location in the condensed consolidated balance sheets

The following summarizes the fair value of the Partnership’s derivative instruments and their location in the condensed consolidated balance sheets as of June 27, 2020 and September 28, 2019, respectively:

 

 

 

As of June 27, 2020

 

 

As of September 28, 2019

 

Asset Derivatives

 

Location

 

Fair Value

 

 

Location

 

Fair Value

 

Derivatives not designated as

   hedging instruments:

 

 

 

 

 

 

 

 

 

 

 

 

Commodity-related derivatives

 

Other current assets

 

$

1,093

 

 

Other current assets

 

$

4,082

 

 

 

Other assets

 

 

122

 

 

Other assets

 

 

167

 

 

 

 

 

$

1,215

 

 

 

 

$

4,249

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Liability Derivatives

 

Location

 

Fair Value

 

 

Location

 

Fair Value

 

Derivatives not designated as

   hedging instruments:

 

 

 

 

 

 

 

 

 

 

 

 

Commodity-related derivatives

 

Other current liabilities

 

$

3,214

 

 

Other current liabilities

 

$

3,360

 

 

 

Other liabilities

 

 

 

 

Other liabilities

 

 

 

 

 

 

 

$

3,214

 

 

 

 

$

3,360

 

Reconciliation of the beginning and ending balances of assets and liabilities measured at fair value on a recurring basis using significant unobservable inputs

The following summarizes the reconciliation of the beginning and ending balances of assets and liabilities measured at fair value on a recurring basis using significant unobservable inputs:

 

 

 

Fair Value Measurement Using Significant

Unobservable Inputs (Level 3)

 

 

 

Nine Months Ended

June 27, 2020

 

 

Nine Months Ended

June 29, 2019

 

 

 

Assets

 

 

Liabilities

 

 

Assets

 

 

Liabilities

 

Beginning balance of over-the-counter options

 

$

419

 

 

$

 

 

$

1,546

 

 

$

361

 

Beginning balance realized during the period

 

 

(419

)

 

 

 

 

 

(1,488

)

 

 

(361

)

Contracts purchased during the period

 

 

 

 

 

 

 

 

434

 

 

 

 

Change in the fair value of outstanding contracts

 

 

 

 

 

 

 

 

997

 

 

 

 

Ending balance of over-the-counter options

 

$

 

 

$

 

 

$

1,489

 

 

$

 

Effect of the Partnership's derivative instruments on the condensed consolidated statements of operations

The effect of the Partnership’s derivative instruments on the condensed consolidated statements of operations for the three and nine months ended June 27, 2020 and June 29, 2019 are as follows:

 

  

 

Three Months Ended June 27, 2020

 

 

Three Months Ended June 29, 2019

 

Derivatives Not Designated

as Hedging Instruments

 

Unrealized Gains (Losses)

Recognized in Income

 

 

Unrealized Gains (Losses)

Recognized in Income

 

 

 

Location

 

Amount

 

 

Location

 

Amount

 

Commodity-related derivatives

 

Cost of products sold

 

$

861

 

 

Cost of products sold

 

$

138

 

 

  

 

Nine Months Ended June 27, 2020

 

 

Nine Months Ended June 29, 2019

 

Derivatives Not Designated

as Hedging Instruments

 

Unrealized Gains (Losses)

Recognized in Income

 

 

Unrealized Gains (Losses)

Recognized in Income

 

 

 

Location

 

Amount

 

 

Location

 

Amount

 

Commodity-related derivatives

 

Cost of products sold

 

$

(1,077

)

 

Cost of products sold

 

$

(7,252

)

Fair Value of the Partnership's Senior Notes .  Based upon quoted market prices (a Level 1 input), the fair value of the Senior Notes (also defined below in Note 10) of the Partnership are as follows:

 

 

As of

 

 

 

June 27,

 

 

September 28,

 

 

 

2020

 

 

2019

 

5.5% senior notes due June 1, 2024

 

$

537,626

 

 

$

540,094

 

5.75% senior notes due March 1, 2025

 

 

253,125

 

 

 

253,178

 

5.875% senior notes due March 1, 2027

 

 

351,750

 

 

 

354,375

 

 

 

$

1,142,501

 

 

$

1,147,647